It’s been an uncomfortable stretch for fans of Healthcare stocks, with names across the board losi... Read More
Advances in clinical trials should move the needle big time on biopharm company NervGen Pharma (Ner... Read More
Paradigm Capital analyst Scott McAuley is staying bullish on NervGen Pharma (NervGen Pharma Stock Q... Read More
Chelsea Stellick of iA Capital Markets continues to have a positive outlook on NervGen Pharma (NervG... Read More
It seems fair to say that biotech hasn’t been the hottest of fields for much of this year. Money c... Read More
Chelsea Stellick of iA Capital Markets is staying bullish on biopharm company NervGen Pharma (NervG... Read More
Paradigm Capital analyst Scott McAuley believes NervGen Pharma (NervGen Pharma Stock Quote, Chart, N... Read More
Industrial Alliance Securities analyst Chelsea Stellick has launched coverage of NervGen Pharma (Ner... Read More